- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Indiana University
Headquarters: IN, United States of America
Website: http://www.indiana.edu
Year Founded: 1820
Status: Non-biopharma
Biopharma related deals can be found by searching the organization's name in the Deals Module.
BioCentury | Aug 26, 2024
Finance
Three’s a crowd? MBX follows Bicara, Zenas into IPO queue
Indiana-based developer of long-acting peptide therapeutics is latest mid-to-late-stage biotech to seek NASDAQ listing
BioCentury | Feb 10, 2024
Discovery & Translation
Science spotlight: Moonlight’s enhanced T cells; plus a HUNK inhibitor and more
BioCentury’s roundup of translational innovations
BioCentury | Nov 2, 2023
Management Tracks
Sam Raha named COO at Myriad
Plus: Endeavor hires a new CMO, and updates from Jasper, Syantra, Ocuphire, Senisca and more
BioCentury | Oct 20, 2023
Discovery & Translation
Targeted protein degrader design insights; plus Long COVID, obesity and more
BioCentury’s roundup of translational innovations
BioCentury | Oct 12, 2023
Distillery Therapeutics
Overexpressing LIPTER for metabolic disorder-associated heart diseases
BioCentury | Sep 9, 2023
Discovery & Translation
Targeting IRE1 in KRASi-resistant tumors; plus AZ’s Cas9 variant and more
BioCentury’s roundup of translational innovations
BioCentury | Mar 23, 2023
Regulation
Tofersen panel bolsters case for neurofilament as ALS surrogate endpoint
FDA advisory committee backs accelerated approval of Biogen therapy, but rejects full approval
BioCentury | Dec 7, 2022
Distillery Therapeutics
MTHFD2 inhibition for UQCR110-deficient ovarian cancer
Items per page:
1 - 10 of 164